The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of secukinumab on moderate-to-severe scalp psoriasis: Results of a 24-week, randomized, double-blind, placebo-controlled phase 3b study

Published:2017-10 Issue:4 Volume:77 Page:667-674
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Bagel Jerry,Duffin Kristina Callis,Moore Angela,Ferris Laura K.,Siu Kimberly,Steadman Jennifer,Kianifard Farid,Nyirady Judit,Lebwohl Mark

Publisher

Elsevier BV

Subject

Dermatology

Reference22 articles.

1. Management of scalp psoriasis: current perspectives;Blakely;Psoriasis: Targets and Therapy,2016

2. Scalp psoriasis: a review of current topical treatment options;Papp;J Eur Acad Dermatol Venereol,2007

3. Quality of life in patients with scalp psoriasis;Zampieron;G Ital Dermatol Venereol,2015

4. Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex;Sampogna;Acta Derm Venereol,2014

5. Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails;Kragballe;Curr Probl Dermatol,2009

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis;Expert Review of Clinical Pharmacology;2024-07-12

2. Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study;Journal of the American Academy of Dermatology;2024-07

3. The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2024-05-24

4. A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp;Dermatology Practical & Conceptual;2024-04-30

5. Tobacco smoking negatively influences the achievement of greater than three-quarters reduction in psoriasis area and severity index after eight weeks of treatment among patients with psoriasis: Findings from a prospective study;Tobacco Induced Diseases;2024-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3